SCHEMBL15870532

SCHEMBL15870532

OC[C@H](Nc1cncc(-c2cccnc2)c1)c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNC P24863 2/20 0.63
▸ CDK8 P49336 2/20 0.63
▸ EGFR P00533 4/20 0.55
▸ DHPS P49366 1/20 0.52
▸ CYP1A2 P05177 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ CFTR P13569 1/20 0.50
▸ GOPC Q9HD26 1/20 0.50
▸ FDPS P14324 1/20 0.49
▸ MAPKAPK2 P49137 1/20 0.45
▸ CDK2 P24941 1/20 0.45
▸ CDK7 P50613 1/20 0.45
▸ CCNT1 O60563 2/20 0.45
▸ CDK9 P50750 2/20 0.45
▸ KCNA5 P22460 2/20 0.44
▸ FGFR1 P11362 2/20 0.43
▸ FGFR2 P21802 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15870558 0.86 CCNC (0.62) CCNCCDK8EGFRDHPSFDPS
SCHEMBL15870580 0.85 CCNC (0.61) CCNCCDK8EGFRFDPSMAPKAPK2
SCHEMBL15870512 0.85 CCNC (0.61) CCNCCDK8EGFRDHPSFDPS
SCHEMBL15870552 0.84 CCNC (0.64) CCNCCDK8EGFRFDPSMAPKAPK2
SCHEMBL15870506 0.84 CCNC (0.64) CCNCCDK8FDPSMAPKAPK2CDK2
SCHEMBL15870515 0.84 CCNC (0.64) CCNCCDK8EGFRCYP1A2CYP3A4
SCHEMBL15870508 0.84 CCNC (0.64) CCNCCDK8EGFRFDPSMAPKAPK2
SCHEMBL15870566 0.82 CDK8 (0.61) CCNCCDK8DHPSFDPSMAPKAPK2
SCHEMBL15870541 0.82 CCNC (0.67) CCNCCDK8EGFRFDPSCDK2
SCHEMBL15864390 0.82 CCNC (0.58) CCNCCDK8EGFRFDPSCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014106606-A1 NOVE PHENYL/PYRIDINE SERIES SUBSTITUED BY HYDROXYETHYLAMINO FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2014-07-10 — — WO disclosed
Send feedback